Overview

Effects of Medications in Patients With Hypogonadism

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The aim of the present study was to demonstrate the influences of three different treatment strategies on biochemical parameters and testicular volume (TV) in patients with idiopathic hypogonadotropic hypogonadism (IHH).
Phase:
Phase 4
Details
Lead Sponsor:
Gulhane School of Medicine
Treatments:
Chorionic Gonadotropin
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate